drugset / Trial / NCT00120874
Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
Phase 4
Completed
20 enrolled
NYU Langone Health
Fisher Center for Alzheimer's Research Foundation · collabForest Laboratories · collab
RandomizedParallel-groupSingle-blind
Summary
The purpose of this study is to determine whether a comprehensive, individualized management approach with caregiver training and medication with memantine will alleviate symptoms in community dwelling patients with moderate to severe Alzheimer's disease.
Timeline
- Start
- 2006-08
- Primary completion
- 2011-11
- Completion
- 2011-11
Publications
- Background Reisberg B, Kenowsky S, Franssen EH, Auer SR, Souren LE. Towards a science of Alzheimer's disease management: a model based upon current knowledge of retrogenesis. Int Psychogeriatr. 1999 Mar;11(1):7-23. doi: 10.1017/s1041610299005554.
- Background Teri L, Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, Barlow WE, Kukull WA, LaCroix AZ, McCormick W, Larson EB. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA. 2003 Oct 15;290(15):2015-22. doi: 10.1001/jama.290.15.2015.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Memantine | Unknown | 10 mg | — |